FDA Warning Letter — BP
The FDA took a Warning Letter action against BP on Jan 5, 2017 (Minneapolis, MN). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- BP
- Date
- Jan 5, 2017
- Fiscal Year
- 2017
- Product Type
- Tobacco
- Center
- CTP
- Location
- Minneapolis, MN (United States)